Allemann Samuel S, Hersberger Kurt E, Arnet Isabelle
Pharmaceutical Care Research Group, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
Integr Pharm Res Pract. 2015 Nov 6;4:167-174. doi: 10.2147/IPRP.S90923. eCollection 2015.
To collect opinions on medication management aids (MMAs) in general and on an electronic MMA (e-MMA) dispensing prepackaged polypharmacy in sealed pouches.
The setting involved community-dwelling older adults in Basel, Switzerland, in 2013.
The study involved 1) a 14-day trial with the e-MMA and 2) a focus group to identify general attributes of MMAs, their applicability to the e-MMA, and possible target groups for the e-MMA.
Six participants using long-term polypharmacy and willing to try new technologies completed the 14-day trial and participated in the focus group. Inductive content analysis was performed to extract data.
Participants rated ten of 17 general attributes as clearly applicable to the e-MMA and five as unsuitable. Attributes pertained to three interrelating themes: product design, patient support, and living conditions. Envisaged target groups were patients with time-sensitive medication regimens, patients with dementia, the visually impaired, and several patients living together to prevent accidental intake of the wrong medication.
The evaluated e-MMA for prepackaged polypharmacy met the majority of the requirements set for an MMA. Patients' living conditions, such as mobility, remain the key determinants for acceptance of an e-MMA.
收集关于药物管理辅助工具(MMAs)的总体意见,以及关于一种电子药物管理辅助工具(e-MMA)的意见,该工具用于预包装多药复方的密封药袋配药。
该研究于2013年在瑞士巴塞尔针对社区居住的老年人展开。
该研究包括1)一项为期14天的e-MMA试验,以及2)一个焦点小组,以确定MMAs的一般属性、其对e-MMA的适用性以及e-MMA的可能目标群体。
六名长期使用多药复方且愿意尝试新技术的参与者完成了为期14天的试验并参与了焦点小组。采用归纳性内容分析法提取数据。
参与者认为17项一般属性中的10项明显适用于e-MMA,5项不适用。这些属性涉及三个相互关联的主题:产品设计、患者支持和生活条件。设想的目标群体包括用药方案有时间要求的患者、痴呆患者、视力受损者以及一些共同居住以防误服药物的患者。
评估的预包装多药复方e-MMA符合为MMAs设定的大多数要求。患者的生活条件,如行动能力,仍然是接受e-MMA的关键决定因素。